Immunolabeling with immune complexes of primary and secondary antibodies offers an attractive method for detecting and quantifying specific antigen. Primary antibodies maintain their affinity for specific antigen after labeling with Fab fragments in vitro. Incubation of these immune complexes with excess normal serum from the same species as the primary antibody prevents free Fab fragments from recognizing immunoglobulin. Effectively a hybrid between traditional direct and indirect immunolabeling techniques, this simple technique allows primary antibodies to be non-covalently labeled with a variety of reporter molecules as and when required. Using complexes containing Fab fragments that recognize both the Fc and F(ab') 2 regions of IgG, we show that this approach prevents nonspecific labeling of endogenous immunoglobulin, can be used to simultaneously detect multiple antigens with primary antibodies derived from the same species, and allows the same polyclonal antibody to be used for both antigen capture and detection in ELISA.
S ince its inception over 60 years ago (Coons et al. 1941 (Coons et al. ,1942 , immunocytochemistry (ICC) has made an almost unparalleled contribution to a wide variety of fields among the life sciences. The use of antibodies to detect and localize individual or multiple antigens in situ remains a powerful and widely exploited technology (Brandtzaeg 1998; Coleman 2000) .
ICC was first applied to the simultaneous detection of multiple antigens within a single sample using directly conjugated primary antibodies (Bernier and Cebra 1964) . Subsequent advances in optical and digital imaging (Schrock et al. 1996) , in conjunction with the availability of fluorescent dyes with sufficiently distinct emission spectra (Panchuk-Voloshina et al. 1999) , have allowed directly conjugated antibodies to be used to discriminate as many as seven different antigens in a single sample (Tsurui et al. 2000) . However, covalent labeling of antibodies is not a routine procedure in the majority of laboratories, requires relatively large quantities of purified antibody (Mao 1999 ) and, to maintain flexibility for multilabeling experiments, it is often necessary to have a choice of several different fluorophore conjugates of each primary and control antibody. These factors, together with the widely held perception that direct ICC is relatively insensitive (Mao 1999) , have led the majority of researchers to rely on the indirect method (Coons et al. 1955) for their multilabeling requirements (Staines et al. 1988; Ferri et al. 1997) .
The use of labeled secondary anti-immunoglobulin (Ig) antibodies in the indirect method introduces the possibility of spurious staining resulting from crossreactions with endogenous Ig and between different primary and secondary antibody combinations. Although indirect ICC has been used to detect up to four antigens in the same sample using primary antibodies derived from different species and species-specific secondary antibodies (Ferri et al. 1997) , it is often necessary to use primary antibodies derived from the same host species in multilabeling studies. The challenge imposed by this situation, i.e., the need to differentiate Brown, Pemberton, Wright, Miller two or more primary antibodies that have virtually identical antigenic properties, is essentially the same as that faced when attempts are made to localize antigens using primary antibodies derived from the same species as the sample material. Tuson et al. (1990) first described the use of preformed immune complexes of primary and secondary antibodies to prevent nonspecific labeling of endogenous Ig when probing human tissues with human monoclonal antibodies. Effectively a hybrid of indirect and direct ICC, this technique involves non-covalent labeling of the primary antibody with a covalently labeled secondary antibody in vitro. After absorption of unbound secondary antibody paratopes with excess serum from the same species as the primary antibody, the resultant complexes retain the antigen specificity of the primary antibody but do not crossreact with endogenous Ig when applied to tissue samples homologous to the primary antibody species (Tuson et al. 1990; Krenacs et al. 1991) . This technique has been adapted to allow indirect dual labeling with primary antibodies derived from the same species (Kroeber et al. 1998 ). However, the use of divalent secondary antibodies in these protocols may lead to the formation of crosslinked complexes, and the ratio of primary to secondary antibodies must be carefully optimized (Hierck et al. 1994; Lu and Partridge 1998) . The use of monovalent IgG Fc-specific Fab fragments avoids this issue (van der Loos and Gobel 2000) and has been developed commercially by DakoCytomation (ARK; DakoCytomation, Ely, UK) and Molecular Probes (Zenon; Eugene, OR).
Here we describe a method for the in vitro noncovalent labeling of primary antibodies with commercial monovalent Fab fragments that recognize both the Fc and F(ab') 2 regions of IgG (Jackson ImmunoResearch Laboratories; West Grove, PA). The resultant immune complexes do not crossreact with endogenous Ig, can be used to simultaneously detect multiple antigens with primary antibodies derived from the same species, and allow the same polyclonal antibody to be used for both antigen capture and detection in ELISA.
Materials and Methods
Unless stated otherwise, reagents were purchased from Fisher Scientific UK (Loughborough, UK). All experimental procedures involving laboratory animals were approved by the University of Edinburgh's Biological Services ethical review committee and were performed under license, as required by the United Kingdom's Animals (Scientific Procedures) Act 1986.
Antibodies
Normal sera were heat-inactivated at 59C for 2 hr before use. Purified and fluorescein isothiocyanate (FITC)-conjugated monoclonal mouse IgG 1 anti-␤ -catenin (clone 14), pu-rified and FITC-conjugated control mouse IgG 1 (clone MOPC-21), purified monoclonal rat IgG 2a anti-mouse integrin-␤ 1 (clone KM16), rat IgG 2a anti-human integrin-␣ 6 (clone GoH3), and control rat IgG 2a (clone R35-95) were purchased from BD Biosciences (Cowley, UK). Rat IgG 2a anti-integrin-␤ 7 (clone M293) hybridoma supernatant and purified rat IgG 2a anti-integrin-␣ E (clone M290) were provided by Dr. Peter Kilshaw (Babraham Institute; Babraham, Cambridge, UK) . Polyclonal rat and sheep anti-mouse mast cell protease-2 (mMCP-2) antibodies were prepared as described previously (Pemberton et al. 2003) . Secondary goat anti-mouse IgG and anti-rat IgG monovalent Fab fragments (Jackson Immu-noResearch Laboratories) were purchased from Stratech Scientific (Soham, UK).
Generation of Mouse Mucosal Mast Cell Homologues
Bone marrow cells prepared from 12-week-old male BALB/c mice were cultured for 21 days ex vivo in the presence of recombinant human TGF-␤ 1 (1 ng/ml; Sigma-Aldrich, Poole, UK), recombinant mouse IL-3 (1 ng/ml; R & D Systems, Abingdon, UK), recombinant mouse IL-9 (5 ng/ml; R & D Systems), and recombinant mouse SCF (50 ng/ml; PeproTech EC, London, UK) as described previously (Miller et al. 1999; Wright et al. 2002; Brown et al. 2003) .
Tissue Samples
Freshly dissected jejunum samples from normal 129 and BALB/c mice (B and K Universal; Hull, UK) were embedded in OCT compound (BDH Laboratory Supplies; Poole, UK) and snap-frozen in isopentane cooled on dry ice. Cryostat sections (10 m) were mounted on Snow Coat X-tra charged slides (Surgipath Europe; Peterborough, UK), airdried for 10 min, and stored at Ϫ 70C.
Fixation and 3,3 Ј -Diaminobenzidine Pretreatment of Tissue Sections
Sections were thawed for 10 min at 21C, fixed in absolute methanol for 10 min at Ϫ 20C, and air-dried for a further 10 min under forced air. Sections were washed and rehydrated in PBS containing 0.5% Tween-80 (Sigma-Aldrich). Eosinophil auto-fluorescence was quenched using a modified version of the procedures described by Kingston and Pearson (1981) and Valnes and Brandtzaeg (1981) . Non-eosinophilderived endogenous peroxidase activity was quenched for 30 min with 1% H 2 O 2 in PBS ϩ 0.5% Tween-80. Sections were then washed with PBS and incubated for 3 min with DAB (3,3 Ј -diaminobenzidine) substrate (Vector Laboratories; Peterborough, UK). Sections were washed thoroughly with PBS before proceeding with ICC.
Primary Antibody-Fab Fragment Complex Formation Kinetics
Immulon-4 96-well microtiter plates (Thermo Shandon) were coated overnight at 4C with 50 l/well of polyclonal sheep anti-mMCP-2 (1 g/ml in pH 9.6 carbonate buffer). Wells were washed (six times with 0.15 M NaCl ϩ 0.05% Tween-20) and alternate columns incubated for 1 hr at 21C with 50 l of purified mMCP-2 (Pemberton et al. 2003) diluted to 5 ng/ml in ELISA buffer (pH 7.4 PBS ϩ 0.05% Tween-20). The remaining columns were incubated with ELISA buffer alone to provide blanks for each time point. Biotinylated mMCP-2-specific Fab fragment complexes were generated as follows. Twelve g of polyclonal rat anti-mMCP-2 were mixed with 12 g of biotinylated goat anti-rat IgG Fab fragments in 120 l of pH 7.4 PBS (1:1 ratio determined through titration). Complex formation was stopped by diluting 20-l aliquots with 980 l of ELISA buffer ϩ 5% heat-inactivated normal rat serum (NRtS: Sigma-Aldrich) at 15 sec, 30 sec, 45 sec, 60 sec, 120 sec, and 240 sec time points and the resultant mixture allowed to stand for Ն 10 min at 21C. Wells were washed and incubated with 50 l of primary antibody-Fab fragment complexes for 60 min at 21C. After washing, wells were incubated for 30 min at 21C with 50 l of streptavidin-biotinylated horseradish peroxidase complex (Amersham Biosciences; Little Chalfont, UK) diluted 1:2000 in PBS ϩ 0.05%Tween-20. Wells were washed and incubated at 21C for 15 min with 50 l of TMB substrate (Insight Biotechnology; Wembley, UK). The reaction was stopped with 0.18 M sulfuric acid and the absorbance (450 nm) of each well measured using a microplate reader (Model 550; Bio-Rad Laboratories, Hemel Hempstead, UK).
Blocking of IgG-specific Fab Fragment Paratopes with Normal Serum
Immulon-4 96-well microtiter plates were coated overnight at 4C with 50 l/well of normal rat IgG (0.1 g/ml in pH 9.6 carbonate buffer). Wells were washed (six times with 0.15 M NaCl ϩ 0.05% Tween-20) and incubated for 1 hr at 21C with 50 l of goat anti-rat IgG Fab fragments (1 g/ml in ELISA buffer) that had been preincubated for 10 min at 21C with various amounts of normal rat serum (0, 0.1, 1, 2, 4, 5, 10, 20, 40, or 80 l of NRtS per g of Fab fragments). Plates were then incubated sequentially with streptavidinbiotinylated horseradish peroxidase complex, TMB substrate, and 0.18 M sulfuric acid before being read as described above.
An mMCP-2 Sandwich ELISA Incorporating Fab Fragment Complexes
Immulon-4 96-well microtiter plates were coated overnight at 4C with 50 l/well of polyclonal rat anti-mMCP-2 (3 g/ ml in pH 9.6 carbonate buffer). Wells were washed (six times with 0.15 M NaCl containing 0.05% Tween-20) and incubated for 1 hr at 21C with 50 l of purified mMCP-2 (Pemberton et al. 2003 ) standard (0.1-5 ng/ml) or samples, diluted appropriately in pH 7.4 PBS ϩ 0.05% Tween-20 ϩ 5% NRtS. Biotinylated mMCP-2-specific Fab fragment complexes were generated as follows. For each 96-well plate, 10 g of polyclonal rat anti-mMCP-2 was incubated at 21C with 10 g of biotinylated goat anti-rat IgG Fab fragments in pH 7.4 PBS (1:1 ratio in 100 l final volume). After 20 min, 4900 l of PBS ϩ 0.05% Tween-20 ϩ 5% NRtS was added and the resultant mixture allowed to stand for 10 min at 21C. Wells were washed and incubated for 1 hr at 21C with 50 l of Fab fragment complexes. Plates were then incubated sequentially with streptavidin-biotinylated horseradish peroxidase complex, TMB substrate, and 0.18 M sulfuric acid before being read as described above. Three independent assays were performed and coefficient of variation (CV) values for intra-( n ϭ 16) and inter-assay ( n ϭ 3) variability were determined using supernatants from mouse mucosal mast cell homologue cultures (day 21) diluted 1:500 in ELISA buffer ϩ 5% NRtS as unknown samples.
Immunocytochemistry
Standard Conditions and Reagents. Unless stated otherwise, ICC procedures were performed at 21C under humidified conditions in a Sequenza immunostaining center (Thermo Shandon; Runcorn, UK). Antibodies and blocking sera were diluted in pH 7.4 PBS containing 0.5 M NaCl and 0.5% Tween-80 (staining buffer). After ICC labeling, samples were washed in PBS and mounted with 1.5 (0.17 mm thickness) glass coverslips (BDH Laboratory Supplies) using Mowiol (pH 8.5) mounting medium (EMD Biosciences; San Diego, CA).
Direct Single-color Labeling of ␤ -Catenin. Tissue sections were washed with staining buffer and blocked for 1 hr in staining buffer containing 10% heat-inactivated normal mouse serum (NMS; Sigma-Aldrich). Sections were then incubated for 1 hr with FITC-conjugated mouse IgG 1 anti-␤ -catenin or FITC-conjugated control mouse IgG 1 diluted to 5 g/ml in staining buffer ϩ 10% NMS and centrifuged at 13,000 ϫ g for 10 min before use to remove insoluble precipitates.
Indirect Single-color Labeling of ␤ -Catenin. Tissue sections were washed with staining buffer and blocked for 1 hr in staining buffer containing 10% heat-inactivated normal goat serum (NGS; Sigma-Aldrich) with or without 50 g/ml of unlabeled goat anti-mouse Fab fragments. Sections were then washed in PBS and incubated for 1 hr with 5 g/ml of purified mouse IgG 1 anti-␤ -catenin or control mouse IgG 1 in staining buffer ϩ 10% NGS. Sections were washed with PBS and incubated for 30 min with FITC-conjugated goat antimouse IgG monovalent Fab fragments diluted to 4 g/ml in staining buffer ϩ 10% NGS and centrifuged at 13,000 ϫ g for 10 min before use to remove insoluble precipitates.
Single-color Labeling of ␤ -Catenin Using Primary Antibody-Fab Fragment Complexes. Tissue sections were washed with staining buffer and blocked for 1 hr with staining buffer containing 10% NMS. During this time, ␤ -cateninspecific and control mouse IgG 1 primary antibodies were incubated for 20 min at 21C with FITC-conjugated mouse IgG specific Fab fragments at a ratio of 1:2 (optimized by titration) in a small volume, typically 10 l/1 g of primary antibody, of staining buffer in a microcentrifuge tube. The resultant complexes were diluted in staining buffer ϩ 10% NMS to give the equivalent concentration of 5 g/ml of primary mouse IgG 1 and incubated for 10 min at 21C to block unbound Fab fragment paratopes. Complexes were then centrifuged at 13,000 ϫ g for 10 min, to remove insoluble precipitates, and incubated with tissue sections for 1 hr. The procedure for generating and using primary mouse antibody-Fab fragment complexes on mouse samples is represented schematically in Figure 1 .
Indirect Single-color Labeling of the Integrin ␣ 6 , ␤ 1 , and ␤ 7 Subunits. Samples were washed with staining buffer and blocked for 1 hr in staining buffer ϩ 10% NMS. Sections were then incubated for 1 hr with 2 g/ml of rat IgG 2a antiintegrin-␣ 6 , ␤ 1 , ␤ 7 , or control rat IgG 2a in staining buffer ϩ 10% NMS. Sections were washed with PBS and incubated for 30 min with cyanine-5 (Cy5) conjugated goat anti-rat IgG monovalent Fab fragments diluted to 4 g/ml in staining buffer ϩ 10% NMS and centrifuged at 13,000 ϫ g for 10 min before use to remove insoluble precipitates.
Simultaneous Detection of Integrin-␣ 6 , ␤ 1 , and ␤ 7 Using Primary Antibody-Fab Fragment Complexes. Tissue sections were washed with staining buffer and blocked for 1 hr with staining buffer containing 10% NRtS. During this time, integrin-specific and control rat IgG 2a primary antibodies were incubated for 20 min at 21C with fluorophoreconjugated rat IgG-specific Fab fragments in a small volume, typically 10 l/1 g of primary antibody, of staining buffer in a microcentrifuge tube. Rat anti-integrin-␤ 1 , anti-integrin-␣ 6 , and control IgG 2a were labeled, separately in solution, with fluorophore-conjugated goat anti-rat IgG Fab fragments at a ratio of 1:2 to yield the following complexes: anti-integrin-␤ 1 -FITC, anti-integrin-␣ 6 -Rhodamine Red-X (RRX), control IgG 2a -FITC, control IgG 2a -RRX, and control IgG 2a -Cy5. Rat IgG 2a anti-integrin-␤ 7 hybridoma supernatant was combined with Cy5-conjugated goat anti-rat IgG Fab fragments at a ratio of 8 l/1 g to yield anti-integrin-␤ 7 -Cy5 Fab fragment complexes. Fab fragment complexes were subsequently diluted to three times their working con-centration in staining buffer ϩ 10% NRtS and incubated for 10 min at 21C to block unbound Fab fragment paratopes. Complexes were then mixed 1:1:1 in various combinations to give final primary antibody concentrations equivalent to 5 g/ml of anti-integrin-␤ 1 /control IgG 2a , 2 g/ml of anti-integrin-␣ 6 /control IgG 2a , and a 1:40 dilution of anti-integrin-␤ 7 hybridoma supernatant/2 g/ml control IgG 2a . Complexes were centrifuged at 13,000 ϫ g for 10 min to remove insoluble precipitates, and incubated with tissue sections for 1 hr. For competitive controls, samples were simultaneously incubated with all three integrin-specific primary antibody-Fab fragment complexes and a 10-fold excess of unlabeled antiintegrin-␣ 6 , -␤ 1 or -␤ 7 .
Simultaneous Detection of Integrin-␣ E and -␤ 7 on Viable Cells Using Primary Antibody-Fab Fragment Complexes
Mouse mucosal mast cell homologues (Miller et al. 1999) were divided into aliquots of 5 ϫ 10 5 cells, washed in two changes of PBS, resuspended in 50 l of PBS containing 10% NRtS, and incubated on ice for 40 min. Rat anti-integrin-␣ E and control IgG 2a were labeled, separately in solution, with FITC-or Cy5-conjugated Fab fragments at a ratio of 1:4 to yield the following complexes: anti-integrin-␣ E -Cy5, control IgG 2a -Cy5, and control IgG 2a -FITC. Rat IgG 2a anti-integrin-␤ 7 hybridoma supernatant was combined with Cy5-conjugated goat anti-rat IgG Fab fragments at a ratio of 8 l/1 g to yield anti-integrin-␤ 7 -FITC Fab fragment complexes. After 20 min, complexes were diluted in PBS ϩ 10% Figure 1 Schematic representation of the procedure for generating and using primary antibody-Fab fragment complexes in the context of using primary mouse antibodies to probe mouse tissues. While the sample is blocked with 10% normal mouse serum (A), primary mouse antibody is incubated for 20 min with fluorescent anti-mouse Fab fragments (B). The resultant primary antibody-Fab fragment complexes are incubated with excess normal mouse serum for 10 min to block free Fab fragment paratopes (C), diluted to working concentration, and centrifuged before use to remove any insoluble precipitates (D). Primary mouse antibody-Fab fragment complexes are then applied to the sample (E), resulting in specific labeling in the absence of spurious crossreactions with endogenous mouse Ig (F).
NRtS to give final concentrations equivalent to 10 g/ml of primary antibody or a 1:20 dilution of M293 hybridoma supernatant and incubated for 10 min at 21C. After centrifugation at 13,000 ϫ g for 10 min to remove insoluble precipitates, 50 l of complexes were added in various combinations to each aliquot of 5 ϫ 10 5 cells. Cells were incubated on ice for 30 min, washed in PBS, and fixed for 5 min in PBS ϩ 2% formaldehyde. Quantitative analysis was performed on 10,000 cells/sample using a flow cytometer (FACSCalibur; Becton Dickinson, Richmond, CA) with linear amplification for forward/side scatter and logarithmic amplification for FITC and Cy5 fluorescence.
Microscopy and Imaging
Fluorescent images were acquired using an MRC-600 confocal laser scanning microscope (CLSM: Bio-Rad Laboratories) mounted on an Axiovert 100 inverted microscope equipped with Plan-Apochromat objective lenses (Carl Zeiss; Oberkochen, Germany). Fluorophores were excited and imaged sequentially using the 488 nm (FITC), 568-nm (RRX), and 647-nm (Cy5) lines from a 15 mW Kr/Ar laser (Bio-Rad Laboratories). Images were prepared for publication using Object-Image (Vischer et al. 1994) and Photoshop (Adobe Systems UK; Uxbridge, UK). Object-Image is a public domain software package, based on NIH Image (Rasband and Bright 1995) , developed by Norbert Vischer (University of Amsterdam; Amsterdam, The Netherlands) and is freely available via the Internet at http://simon.bio.uva.nl/objectimage.html.
Results

Primary Antibody-Fab Fragment Complex Formation
Pilot studies established that primary antibodies labeled in solution with polyclonal anti-IgG (heavy and light chain-specific) Fab fragments retain their ability to recognize specific antigen (Figure 2A ). In agreement with data published by Molecular Probes for their commercial Fc-specific anti-mouse IgG 1 Zenon Fab fragments (Haugland 2002) , biotinylated anti-rat IgG (heavy and light chain-specific) Fab fragments formed immune complexes with polyclonal rat anti-mMCP-2 antibodies within minutes when mixed in a minimal volume (10 l per g of primary antibody). Complex formation occurred within 2-4 min (Figure 2A ) and did not appear to be adversely affected by the presence of glycerol, 0.5% Tween-80, and/or concentrations of up to 0.5 M NaCl (data not shown). A 10-min incubation at 21C with Ն0.1 l of NRtS significantly (pϽ0.01; unpaired Student's t-test with Welch correction) reduced the affinity of 1 g of biotinylated goat anti-rat IgG Fab fragments for normal Rat IgG immobilized on ELISA plates ( Figure 2B ). Maximal inhibition of IgG binding was achieved by incubation with Ն5 l of NRtS per g of biotinylated anti-rat IgG Fab fragments ( Figure 2B ).
Development of a Sandwich ELISA Incorporating Primary Antibody-Fab Fragment Complexes
An mMCP-2-specific ELISA was developed using polyclonal rat antibodies to capture mMCP-2 on the microtiter plate surface and complexes containing the same antibody, together with biotinylated anti-rat IgG Fab fragments at a ratio of 1:1, for quantitative detection of bound mMCP-2 ( Figures 2C-2F ). Incubation of mMCP-2-specific Fab fragments complexes with excess NRtS for 10 min at 21C prevented nonspecific labeling of the capture antibody, allowing the resolution of mMCP-2 concentrations of Ն0.1 ng/ml (Figures 2C-2F) . The sensitivity and dynamic range ob-
Figure 2
Rat anti-mMCP-2 IgG and biotinylated goat anti-rat IgG Fab fragments form immune complexes capable of recognizing mMCP-2 immobilized on ELISA plates within minutes when mixed in vitro (A). Preincubation with NRtS prevents biotinylated anti-rat Fab fragments from binding to immobilized normal rat IgG in a dose-dependent manner (B). A sandwich ELISA was developed using polyclonal rat anti-mMCP-2 Ig as the capture antibody and biotinylated primary antibody-Fab fragment complexes containing the same antibody as the detection reagent (C-F). Standard curves from three independent assays are shown (C-E; error bars represent one SEM; nϭ4). Supernatant from an in vitro mucosal mast cell homologue culture (diluted 1:500; nϭ16) was used as an unknown for the purposes of calculating intra-assay variation (%CV, inset in lower right of C-E) and inter-assay variation (%CV in parentheses in F). tained using this modified version of the assay were similar to those observed for the indirect mMCP-2 ELISA reported by Pemberton et al. (2003) . Intraassay variability was low in all three assays ( Figure  5C , % CV ϭ 4.48; Figure 5D , % CV ϭ 5.73; Figure 5E : % CV ϭ 3.39), and inter-assay variability ( Figure  2F , % CV ϭ 1.14) was lower than that reported using sheep capture and rat detection antibodies (Pemberton et al. 2003) .
Immunofluorescent Labeling of Antigens in Mouse Tissues Using Mouse Primary Antibodies
The hypothesis that Fab fragment complexes can be used to label specific antigen in samples derived from the same species as the primary antibody in the absence of spurious labeling of endogenous Ig was tested using primary mouse antibodies and frozen sections of normal mouse jejunum. Serial sections were probed with ␤-catenin-specific mouse IgG 1 using directly conjugated antibodies, Fab fragment complexes, or indirect ICC (Figure 3) .
Consistent with its association with the intracellular domain of E-cadherin (Ozawa et al. 1990 ), ␤-catenin-specific labeling was most evident on the lateral surfaces (zonula adherens) of epithelial cells ( Figures  3A, 3C, 3E, and 3G ). There was also evidence for diffuse cytoplasmic labeling in this cell type, typically concentrated towards the basement membrane ( Figure  3C , arrows) but no conclusive evidence for ␤-catenin expression within the nuclei of basal crypt enterocytes, as has been described in normal murine colon epithelium (van de Wetering et al. 2002) . Although specific ␤-catenin labeling was most intense in indirectly labeled sections (excitation and exposure conditions: 0.6 numerical aperture objective; 0.05 mW excitation at 488 nm; 35 frames accumulated in fast photon counting mode), there was also considerable nonspecific labeling of endogenous Ig (Figures 3E-3H ). Although this was reduced in sections that had been incubated with excess unlabeled goat anti-mouse Fab fragments before application of the primary antibodies, it was not completely abolished, and plasma cells within the lamina propria commonly fluoresced more intensely than the ␤-catenin primary antibody ( Figures 3E-3F ). Sections labeled with directly conjugated antibodies exhibited considerably less intense specific fluorescence than those labeled using the indirect approach (excitation and exposure conditions: 0.6 numerical aperture objective; 0.15 mW excitation at 488 nm; 170 frames accumulated in fast photon counting mode) but were not compromised by spurious labeling of endogenous Ig (Figures 3A and 3B) . Spurious labeling of endogenous Ig was virtually abolished in sections probed with ␤-catenin-specific and control Fab fragment complexes (Figures 3C and 3D ). Sections stained with ␤-catenin-specific Fab fragment complexes ( Figure 3C ) also exhibited substantially brighter labeling (excitation and exposure conditions: 0.6 numerical aperture objective; 0.15 mW excitation at 488 nm; 70 frames accumulated in fast photon counting mode) than those probed with directly conjugated antibody ( Figure 3A) . These results were successfully reproduced using samples from three other 129 mice and at least two different BALB/c mice. Specific labeling of mouse samples in the absence of crossreactivity with endogenous Ig was also obtained with Fab fragment complexes containing several other primary mouse monoclonals (data not shown).
Triple Immunofluorescent Labeling with Primary Antibodies Derived from the Same Species
Three different rat monoclonal IgG 2a anti-integrin antibodies that produce distinct staining patterns when applied individually to frozen sections of normal mouse jejunum ( Figures 4A-4C) were selected for use in this proof of function study. Rat anti-integrin-␤ 1 ( Figure 4A ) predominantly labeled smooth muscle and endothelial cells within the lamina propria. Rat antiintegrin-␤ 7 labeling ( Figure 4B ) was restricted to leukocytes, the majority of which were located within the epithelium (Figure 4B, arrow) . Rat anti-integrin-␣ 6 labeling ( Figure 4C ) was predominant along the basement membrane (Figure 4C, arrow) but was also present on the basolateral surfaces of epithelial cells and on endothelial cells in the lamina propria ( Figure  4C, arrowhead) . Sections probed with isotype-matched control rat IgG 2a ( Figure 4D ) confirmed staining specificity.
After stabilization with excess serum from the same species as the primary antibody, Fab fragment complexes containing primary antibodies derived from the same species can be mixed and used in multilabeling studies ( Figures 4E-4L ). Images of frozen sections of normal mouse jejunum that were triple-labeled with Fab fragment complexes containing primary rat IgG 2a monoclonal antibodies specific for integrins-␤ 1 (pseudocolored red), -␤ 7 (pseudocolored green), and integrin-␣ 6 (pseudocolored blue) are shown in Figures  4E and 4F . The staining morphology obtained using anti-integrin-Fab fragment complexes ( Figures 4E-4L ) was virtually identical to that observed with single-color indirect ICC (Figures 4A-4C) . Although there was a reduction in signal intensity, fully saturated images were readily acquired at relatively lowlevel excitation (0.05-0.5 mW) and photon multiplier tube sensitivity (40 frames accumulated in fast photon counting mode using a 1.4 numerical aperture ϫ63 objective). There was little evidence for crossreaction between Fab fragment complexes in triple-labeled samples (Figure 4E and 4F) . Single positive controls, in which control rat IgG 2a -Fab fragment complexes were substituted for two of the anti-integrin antibody- Fab fragment complexes, were used to confirm staining fidelity. Nonspecific background staining was low in all cases and there was negligible evidence for Fab fragment transfer from control antibodies to anti-integrin antibodies (Figures 4G-4I ). Fab fragment complex stability was also examined using competitive controls, where tissue sections were probed with all three anti-integrin-Fab fragment complexes in the presence of a 10-fold excess of unlabeled integrin-␤ 1 (Figure 4J) , -␤ 7 (Figure 4K ), or -␣ 6 ( Figure 4L ) specific antibodies. Excess unlabeled primary antibodies almost completely inhibited Fab fragment complex labeling in all three cases ( Figures 4J-4L) . These results were successfully reproduced using samples from several different 129 and BALB/c mice. They were also largely unaffected by changing the primary antibody/fluorophore combinations, although the signal obtained with Cy5labeled anti-integrin-␣ 6 complexes was commonly so intense that it resulted in substantial bleed-through into the RRX channel.
Dual Fluorescent Labeling of Viable Cells for Analysis by Flow Cytometry
The potential for multilabeling with Fab fragment complexes containing primary antibodies derived from the same species was also investigated in the context of flow cytometry ( Figure 5 ). Analysis was restricted to viable mucosal mast cell homologues (Wright et al. 2002) , identified on the basis of their forward and side scatter characteristics ( Figure 5A ). The majority of cells incubated with integrin-␣ E -and integrin-␤ 7 -specific Fab fragment complexes exhibited bright FITC and Cy5 fluorescence ( Figure 5B ). Consistent with the expression of integrins-␣ E and -␤ 7 as a heterodimer (Kilshaw 1999) , there was a strong correlation between FITC and Cy5 signal intensity in dual-labeled samples ( Figure 5B ). Staining specificity was confirmed using single negative controls in which integrin-␣ E ( Figure 5C ) or integrin-␤ 7 -specific ( Figure 5D ) primary antibodies were substituted with control rat IgG 2a .
Discussion
Various methods involving the sequential application and elution (Nakane 1968) or denaturation (Wang and Larsson 1985; Tornehave et al. 2000) of antibodies have been developed for indirect multilabeling using primary antibodies derived from the same species. However, their application is limited to tissues and antigens that are resistant to damage by the relatively harsh conditions involved. The use of monovalent IgG Fab fragments to block endogenous Ig was first introduced for the screening of human antibodies on human tissue sections (Nielsen et al. 1987) . Monovalent Fab fragments, as opposed to divalent IgG or F (ab') 2 fragments, allow endogenous Ig epitopes to be sterically blocked while eliminating the possibility of crosslinking them with subsequent primary antibody steps. Complete blocking of endogenous Ig with Fab fragments can be difficult to achieve (Nielsen et al. 1987) . Nevertheless, this approach has been adapted for dual-labeling studies using primary antibodies derived from the same species (Lewis-Carl et al. 1993; Negoescu et al. 1994; Donat et al. 1999) . All three methods, although subtly different, rely on indirect labeling of the first antigen followed by (Lewis-Carl et al. 1993) or incorporating (Negoescu et al. 1994; Donat et al. 1999 ) the use of Fab fragments to fully saturate the first primary antibody and block its recognition by the secondary antibody used in the indirect labeling of the second antigen. Brouns et al. (2002) have recently employed this approach, in combination with tyramide signal amplification (Bobrow et al. 1989; Shindler and Roth 1996) , to successfully delineate three different antigens using polyclonal rabbit primary antibodies.
A major drawback to sequential staining methods is that they become increasingly time-consuming as the desired number of labels increases, to the extent that the triple labeling procedure described by Brouns et al. (2002) requires 3 days to perform. Although this can be regarded as a fairly trivial point in the context of labeling fixed samples, prolonged staining times Figure 4 Single-color indirect immunofluorescent labeling of frozen sections from normal mouse jejunum (A-D). Sections were probed with anti-integrin-␤ 1 (A), -␤ 7 (B, arrows highlight intraepithelial leukocytes), -␣ 6 (C, arrow highlights epithelial basement membrane; arrowhead highlights endothelium), or isotype-matched control (D) antibodies. Specific labeling was visualized using Cy5-conjugated secondary antibodies. Triple-color immunofluorescent labeling of frozen sections from normal mouse jejunum with Fab fragment complexes containing primary antibodies derived from the same host species (E-L). Primary rat IgG 2a antibodies were prelabeled with fluorophore-conjugated anti-rat IgG Fab fragments to generate the following Fab fragment complexes: anti-integrin-␤ 1 -FITC or control IgG 2a -FITC (pseudocolored red); anti-integrin-␤ 7 -Cy5 or control IgG 2a -Cy5 (pseudocolored green); and anti-integrin-␣ 6 -RRX or control IgG 2a -RRX (pseudocolored blue). Images of murine jejunum labeled with all three integrin-specific Fab fragment complexes (E,F). (G-I) High-resolution images from sections probed with various combinations of anti-integrin and control IgG 2a -Fab fragment complexes. (G) Anti-integrin-␤ 1 (red), control (blue), and control (green). (H) Control (red), anti-integrin-␤ 7 (green), and control (blue). (I) Control (red), control (green), and anti-integrin-␣ 6 (blue). (J-l) High-resolution images of jejunal epithelium probed with all three anti-integrin-Fab fragment complexes plus a 10-fold excess of unlabeled rat IgG 2a anti-integrin-␤ 1 (J), -integrin-␤ 7 (K), or -integrin-␣ 6 (L). Identical CLSM settings were used to acquire images from samples probed with anti-integrin antibodies and their respective controls. Bars ϭ 10 m. Brown, Pemberton, Wright, Miller can severely reduce the viability of live samples, precluding the use of most sequential labeling procedures in applications such as flow cytometry. The use of preformed immune complexes (Tuson et al. 1990 ) offers an alternative approach to sequential labeling and has the potential to substantially reduce the amount of time required for multilabeling studies using primary antibodies raised in the same host species.
Here we describe a method by which primary antibodies can be non-covalently labeled in vitro with a reporter molecule using monovalent Fab fragments that recognize both the Fc and F(ab') 2 regions of IgG (Figure 1) . Like primary antibodies labeled with Fcspecific Fab fragments (van der Loos and Gobel 2000; Martin et al. 2003) , such as the ARK (DakoCytomation) and Zenon (Molecular Probes) reagents, these immune complexes retain the antigen specificity of the original primary antibody and can be used in a variety of applications that would normally require covalently conjugated primary antibodies. The monovalent nature of Fab fragments prevents the formation of large crosslinked complexes and, once stabilized with excess serum from the same species as the primary antibody, Fab fragment complexes can be used to label specific antigen in tissues homologous to the primary antibody without resulting in spurious labeling of endogenous Ig (Figure 3 ). Furthermore, multiple Fab fragment complexes containing the same species and isotype of primary antibodies can be combined and used to simultaneously label multiple antigens in the same sample in a single incubation, in the absence of erroneous crossreactions between different primary and secondary antibody pairs (Figures 4 and 5) . Although lower than that obtained through conventional indirect ICC (Figure 4) , the signal-to-noise ratio achieved with primary antibody-Fab fragment complexes typically exceeds that normally achievable using covalently conjugated primary antibodies (Figure 3) . Moreover, the ability to label as much, or as little, primary antibody with a choice of different reporter molecules as and when required provides a similar level of flexibility as traditional indirect ICC.
The ratio of primary antibodies to Fab fragments required for the formation of complexes that produce optimal immunolabeling of specific antigen does not appear to vary dramatically with primary antibody specificity or species. Primary antibody to Fab fragment ratios of 1:2-1:4 (weight for weight, based on concentration data supplied by manufacturers) typically produced optimal results with primary mouse and rat monoclonal antibodies, and over-labeling, to the extent that their affinity for specific antigen is significantly compromised, was not a significant problem. Preliminary results suggest that similar primary Figure 5 Flow cytometric analysis of mouse mucosal mast cell homologues dual-labeled with Cy5-and FITC-labeled Fab fragment complexes containing primary rat IgG 2a antibodies specific for integrin-␣ E and -␤ 7 . Primary rat IgG 2a antibodies were prelabeled with fluorophore-conjugated anti-rat IgG Fab fragments to generate the following Fab fragment complexes: anti-integrin-␤ 7 -FITC, control IgG 2a -FITC, antiintegrin-␣ E -Cy5, and control IgG 2a -Cy5. (A) Viable cells (outlined) were identified on the basis of their forward (x-axis, FSC-H) and side scatter characteristics (y-axis, SSC-H). (B) Cells probed with Fab fragment complexes specific for both components of the integrin-␣ E ␤ 7 heterodimer exhibited closely correlated FITC (x-axis, FL1-H) and Cy5 (y-axis, FL4-H) fluorescence. (C,D) Single negative controls, in which control rat IgG 2a was substituted for antiintegrin-␣ E (C) or -␤ 7 (D), were used to confirm Fab fragment complex specificity.
antibodies to Fab fragment ratios produce optimal immunolabeling with Fab fragment complexes containing primary rabbit or goat polyclonal antibodies (data not shown). Primary antibody to Fab fragment ratios can be reduced to 1:1 for the purposes of ELISA quantification of antigen without compromising the sensitivity or dynamic range of the assay. This effectively reduces the requirements for ELISA development to a single species of polyclonal antibody and protein standard. Indeed, the original mMCP-2 sandwich ELISA (Pemberton et al. 2003) , which requires two different species of polyclonal anti-mMCP-2 antibodies, offers no discernible advantage over the modified version of the assay described here (Figures 2C-2F) .
Primary antibody-Fab fragment complexes provide an attractive alternative to covalently conjugated primary antibodies. They can be generated rapidly, as and when required, using inexpensive reagents that are readily available from a variety of commercial sources. Although they do not offer the same level of signal amplification as traditional indirect ICC, they do not crossreact with other immunoglobulins and significantly reduce the amount of time required for simultaneous labeling of multiple antigens. We envisage that primary antibody-Fab fragment complexes, used either alone or in conjunction with indirect and direct ICC, will greatly facilitate the full exploitation of the vast array of fluorescent markers now available and the spectral resolution offered by modern microscopic and flow cytometric equipment. They also have the potential to greatly facilitate sandwich ELISA development.
